Adenovirus 2 and 12 early region 1A (Ad2 and Ad12 E1A) proteins were cleaved during cisplatin-induced apoptosis of Ad-transformed rat and human cells. Cleavage was inhibited in the presence of caspase inhibitors such as Z-VAD-FMK. In Ad12 transformants both 13S and 12S E1A proteins were cleaved at a similar rate. In Ad2 transformants the E1A 13S component was appreciably less stable than the 12S component. In in vitro studies Ad2 and Ad12 E1A 13S and Ad2 12S proteins were rapidly cleaved by caspase 3 whereas Ad12 12S E1A and Ad12 13S E1A were rapidly degraded by caspase 7. Cleavage sites in Ad12 13S proteins for caspase 3 have been determined. Initial cleavage occurred at D24 and D150; this was followed by cleavage at D204 and D242. Caspase-3-mediated cleavage of Ad12 13S E1A destroyed its ability to bind to CBP and TBP but interaction between C terminal E1A polypeptides and CtBP was observed. During viral infection Ad5 and Ad12 E1A 12S proteins were markedly more stable than 13S proteins but no difference was observed in Ad E1A levels in the absence or presence of the caspase inhibitors Z-VAD-FMK or Z-D(OMe)-E(OMe)-V-D(OMe)-CH 2 F. Limited caspase 3 and 10 activation occurred during infection with the E1B 19K Ϫ virus Ad2 pm1722 but little or no activation of caspase 3 was observed during wt virus infection. Examination of protein cleavage during viral infection of A549 cells showed proteolysis of lamin B and PARP in response to Ad5 wt and Ad2 pm1722. Protein degradation in response to both viruses was partially inhibited by Z-VAD-FMK. Following infection of human skin fibroblasts lamin B was degraded, although only limited changes in PARP levels were observed. We have concluded that Ad E1A is cleaved by caspases during apoptosis but not during viral infection. However, some of the processes commonly associated with apoptosis occur during viral infection, particularly with E1B 19K 
INTRODUCTION
Adenovirus early region 1A (Ad E1A) is the first protein expressed after the initiation of viral infection. It regulates the expression of other viral early proteins by means of its interaction with the host cell transcriptional machinery (reviewed in Jones, 1995; Shenk, 1996; Flint and Shenk, 1997; Gallimore and Turnell, 2001 ). Ad E1A is also essential for Ad-mediated transformation although it transforms cells only rarely in isolation (Houweling et al., 1980; Gallimore et al., 1985a) . The frequency of transformation is dramatically increased in the presence of cooperating oncogenes such as Ad E1B or activated ras (Houweling et al., 1980; Gallimore et al., 1985b; Byrd et al., 1988) .
Two major proteins are translated from the Ad E1A gene. They are identical except for the presence of a 30-to 40-amino-acid peptide located toward the C terminus of the larger molecule and are usually designated by the sedimentation coefficients of their mRNAs-12S and 13S (reviewed, for example, in Boulanger and Blair, 1991) . Comparison of the amino acid sequences of Ad E1As from different virus serotypes has allowed regions of particular amino acid homology to be identified (Moran and Mathews, 1987) . These conserved regions (CR) form the binding sites for many of the proteins with which Ad E1A interacts and their integrity is essential for most biological properties of Ad E1A (Bayley and Mymryk, 1994) . Other regions of Ad E1A, however, are also involved in binding to particular cellular proteins. For example, the ATPase components of the 19S proteasome and p400 interact within the N-terminal region of Ad E1A (Turnell et al., 2000; Fuchs et al., 2001 ) while p300/CBP interacts with the N-terminal region of Ad E1A as well as CR1 (Wang et al., 1993; Eckner et al., 1994) . On the other hand, the pRb family of proteins binds only through CR1 and CR2 (Dyson et al., 1992) . Binding to pRb and p300/ CBP is necessary for induction of DNA synthesis and apoptosis by Ad E1A (Howe et al., 1990; Querido et al., 1997a) . The third highly conserved region (CR3) is either entirely or largely missing from the 12S product, dependent on virus serotype. It is particularly important for interaction with TBP (Geisberg et al., 1994) , hSUR2 (Boyer et al., 1999) , and ATF2 (Liu and Green, 1994) and is required for regulation of transcription of both cellular and viral genes. A further region close to the C terminus of Ad E1A is highly conserved in E1As from all virus serotypes and is required for interaction with C-terminal binding protein (CtBP) (Boyd et al., 1993; Schaeper et al., 1995) .
The relationship between adenoviruses and apoptosis is complex (White, 1998 (White, , 2001 Chinnadurai, 1998; Roulston et al., 1999) . It has long been established that deletion of the gene encoding the 19K E1B protein gives rise to viruses which appear to induce apoptosis in infected cells-this is evident as degraded DNA (deg ϩ phenotype) and/or large plaques (lp ϩ phenotype) (Stillman, 1986) . This apoptotic response is generally considered due to activity of Ad E1A and may be either p53 dependent or independent (Lowe and Ruley, 1993; Debbas and White, 1993; Subramanian et al., 1995; Teodoro et al., 1995) . Anti-apoptosis functions are encoded by the Ad E1B genes with the 19K protein being a functional and structural homologue of Bcl-2 (Rao et al., 1992) .
It is now apparent that a critical initiating event in certain apoptotic pathways is cleavage of Bid to tBid (Li et al., 1998; Luo et al., 1998) which promotes homooligomerization of the proapototic Bcl-2 family members Bax and Bak (Wei et al., 2000; Eskes et al., 2000) . This can, in turn, give rise to some of those events commonly associated with apoptosis such as cytochrome c release from mitochondria (Desagher et al., 1999; Wei et al., 2001) . The adenovirus E1B 19K protein binds to Bax (Farrow et al., 1995; Han et al., 1996) which has been conformationally altered by tBid (Perez and White, 2000) . Interaction of AdE1B with Bax prevents exposure of the C-terminal BH2 domain, oligomerization, and TNF-␣-mediated apoptosis (Perez and White, 2000; Sundarajan and White, 2001 ).
As well as being able to induce apoptosis in isolation, Ad E1A can also sensitize cells to TNF␣, resulting in cell lysis (Chen et al., 1987; Duerksen-Hughes et al., 1989) . Mutational analysis has established that this only occurs in human cells with viruses lacking the E1B and E3 regions (Gooding et al., 1991a,b) . Additionally, it has been shown that retention of the ability to bind p300 and pRb is essential for Ad E1A to induce cytolysis (Shisler et al., 1996) . Ad E1A appears to sensitize cells by facilitating TNF␣-dependent activation of caspase 8 (White, 2001 ). This may be achieved by stimulation of c-FLIPs proteasome-mediated degradation by AdE1A (White, 2001) . The larger E1B protein (55K) can also inhibit p53-mediated apoptosis by direct binding to p53 during Ad-induced transformation or, in cooperation with E4orf6, targeting p53 for rapid degradation during viral infection (Querido et al., 1997b (Querido et al., , 2001 Steegenga et al., 1998) .
The distinctive morphological changes that occur in apoptotic cells are attributable to the action of a series of apoptosis-specific proteases termed caspases (Cohen, 1999; Thornberry and Lazebnik, 1998) . About 15 of these enzymes have been identified in mammalian cells so far. They are normally present in an inactive proenzyme form and are activated either by autolysis or by cleavage by other caspases. Caspases have been divided into two general groups-initiators and effectors (Thornberry and Lazebnik, 1998 (Wen et al., 1997) and hPAK65 (Lee et al., 1997) (Harvey et al., 1998) , cell cycle regulators such as pRb (Jaenicke et al., 1996) , and p21 (Gervais et al., 1998) proteins involved in the p53 pathway such as MDM2 (Ehardt et al., 1997) and ATM (Lu et al., 1998) , proteins which play an integral role in the apoptotic response (e.g., ICAD [also known as DFF45], an inhibitor of caspase activated nuclease [Liu et al., 1997] or Bcl2 [Cheng et al., 1997] ), as well as a large number of cytoskeletal components, are degraded during apoptosis. Thus, in this latter category actin, vimentin, and keratins are all substrates for caspases, as are catenins and cadherins (Caulin et al., 1997; Brancolini et al., 1997; Schmeiser et al., 1998; Schmeiser and Grand, 1999) . While caspase-dependent cleavage of substrate molecules can serve to inactivate protein function, this is not always the case. Caspase-mediated proteolysis can result in a truncated product with radically different properties. Thus, gelsolin degrades actin polymers in a Ca 2ϩ -dependent process, whereas the cleaved polypeptide encourages disassembly of actin filaments in a Ca 2ϩ -independent manner (Kothakota et al., 1997) . In the study presented here, we have examined the possibility that the Ad E1A proteins, as well as being able to induce apoptosis, can also be added to the list of substrates for caspases. It has been shown that Ad2 and Ad12 13S proteins are readily degraded in vitro by caspase 3 but the 12S components are less susceptible. Ad12 12S protein, however, is a substrate for caspase 7. Ad E1A is also degraded by a caspase-mediated mechanism during Ad/TNF␣-induced apoptosis. During viral infection, however, Ad E1A is degraded in a caspaseindependent manner although limited caspase 3 and caspase 10 activation occurs during infection with certain mutant and wild-type viruses. PARP and lamin B degradation has also been noted during viral infection of A549 cells and this proteolysis has been partially inhibited with caspase inhibitors. These data suggest caspase-3-independent proteolysis of Ad E1A during adenoviral infection with cellular proteins being degraded in a caspase-dependent and -independent manner.
RESULTS

Cleavage of Ad E1A during apoptosis
It is now firmly established that a large number of cellular proteins are substrates for caspases during the later stages of apoptosis. We were interested to know whether viral proteins, and in particular adenovirus E1A, which is able to induce apoptosis, were also degraded. Apoptosis was induced in BRKs transformed with Ad12 E1A, by the addition of the DNA damaging agent cisplatin. It can be seen from Fig. 1A that increasing concentrations of cisplatin caused apoptosis and consequent degradation of Ad E1A. Figure 1B shows loss of Ad12 E1A after the addition of cisplatin (16 g/ml) and contemporary activation of caspase 3 (Fig. 1C) . This is evident as a reduction in level of the inactive 32K procaspase and increase in level of the activated 17K and 12K caspase components. Similar results were obtained when human cells transformed with Ad2 E1A ϩ mutant N ras were treated with cisplatin. Degradation of Ad2 E1A and activation of caspase 3 can be clearly observed (Figs. 1D and 1E) . To confirm that the reduction in Ad E1A was attributable to caspase activity, cells were treated with cisplatin in the presence and absence of the caspase inhibitor Z-VAD-FMK (Figs. 2A and 2B, respectively) . It can be seen that Z-VAD-FMK inhibits cleavage of Ad12 E1A and apoptosis-as determined by microscopic examination of acridine-orange-stained cells. Similar results were obtained for the Ad2 E1A ϩ activated ras cells treated with cisplatin and Z-VAD-FMK (data not shown).
Cleavage of Ad E1A by purified caspase 3
Caspases can be broadly divided into initiators and effectors, the latter class being responsible for the proteolysis of most proteins during apoptosis (Thornberry and Lazebnik, 1998) . To determine which caspases were capable of degrading Ad E1A, in vitro translated Ad2 and Ad12 E1A were incubated with purified active caspases. Figure 3 shows that the larger (i.e., 13S) Ad2 and Ad12 E1A proteins were rapidly cleaved at a site close to the C or N terminus by caspase 3, causing a small reduction in molecular weight at early times (i.e., at 4 min). At later times a much lower molecular weight polypeptide was the predominant product with both E1A serotypes (Figs. 3A [fragment 3] and 3C). Caspase 3 is much less effective in the degradation of the 12S proteins. Ad12 E1A 12S is cleaved to a very limited extent at relatively late times (Fig. 3B) . Cleavage of Ad2 E1A 12S is rapid at a site close to one end of the protein (as is the case for Ad2 E1A 13S- Fig. 3C ) but further degradation does not occur within the time span of the experiment (Fig. 3D) . The in vitro translated proteins were also incubated with purified caspases 6, 7, and 8 (Fig. 4) . As might be expected, caspase 8 had very limited effect on any of the E1A proteins (left), since it is an initiator rather than effector caspase (confirmation that caspase 8 was active is provided by data presented in Fig. 5 ). Caspase 7 (center) rapidly cleaved Ad12 E1A 12S (top center) with loss of a polypeptide from one end of the molecule. It also had activity against Ad12 E1A 13S with a slight reduction in molecular weight being apparent after 15 min. Caspase 7 cleaved the Ad2 E1A 12S and 13S proteins at later times, giving rise to a slightly truncated product. Caspase 6 (right) had only very limited activity, being able to cleave the proteins (with the exception of Ad12 E1A 12S) close to one end at late times. Proteolytic cleavage by caspase 3 of in vitro translated Ad12 E1A 13S could be inhibited by Z-DEVD-FMK, Z-YVAD-FMK, and Z-VAD-FMK (data not shown). From these in vitro studies it appears that both Ad12 E1A 12S and 13S proteins serve as substrates for caspases, while in the case of Ad2/5 E1A the 13S protein is much more readily degraded than the smaller 12S protein. However, when sufficient caspase 3 was present almost all of the Ad2/5 E1A in lysates of Ad5E1 HER911 (Fig. 5A ) or Ad2 E1A ϩ N ras HER313A cells (data not shown) was degraded. Similarly, rapid cleavage of PARP and lamin B was seen. When caspase 8 rather than caspase 3 was added to the lysates, PARP and lamin B cleavage was also observed, although at rather later times. Some cleavage of Ad E1A was noted although this is almost certainly attributable to secondary effects of the enzyme, for example, the cleavage and activation of caspase 3. As expected, the addition of caspase 8 to the lysates caused rapid cleavage of the intact caspase 3 present (Fig. 5B) . No degradation of Ad E1A, PARP, or lamin B was observed following incubation in the absence of added caspases (data not shown).
To compare the relative stabilities of 12S and 13S E1A products in vivo Ad12 E1A transformed rat cells (Ad12 E1A HLBRK7) and Ad2 E1A ϩ mutant ras transformed human cells (Ad2 E1A ϩ N ras HER 313A) were treated with cisplatin. After various times cells were harvested. Ad E1A 13S and 12S proteins were separated by electrophoresis at pH 8.3 in the absence of SDS but in the presence of 8 M urea (Grand and Gallimore, 1984) . It can be seen from the Western blots presented in Fig. 6 that degradation of the 12S and 13S E1A proteins occurred at a similar rate in the apoptotic Ad12 E1A transformants (top). In the case of Ad2 E1A, however, the 12S product was much more stable than the 13S protein (bottom). Similar results were obtained with Ad12 E1A HLBRK5, Ad12 E1A ϩ E1B 19K HLBRK2, Ad12 E1A ϩ E1B 19K HLBRK3, Ad12 E1A ϩ E1B 19K HLBRK4, Ad12 E1A ϩ Nras HER 414B, Ad12 E1A ϩ Nras HER 387.2, Ad2 E1A ϩ Nras HER 313C, and Ad2 E1A ϩ Hras HER 414.2 cells when they were treated with cisplatin (data not shown). These results are a reflection of the in vitro observations presented in Figs. 3 and 4.
Caspase 3 cleavage sites in purified Ad12 13S E1A
To determine the caspase 3 cleavage sites present in Ad12 E1A13S, purified protein was incubated with caspase 3 at 37°C. At various times aliquots were withdrawn from the reaction mix and proteolysis was stopped by the addition of SDS-PAGE sample buffer. Afterward, SDS-PAGE polypeptide products were electrophoretically transferred to PVDF membranes. These were visualized by staining with Ponceau S (1% in 3% trichloroacetic acid). Areas of the filters staining for polypeptides were then subjected to amino acid sequencing and amino acid analysis. From the sequencing it is clear where each peptide commences. The results of the amino acid analysis, approximate molecular weight (from the SDS-PAGE), and knowledge of other cleavage sites were used to predict the dimensions of the products of caspase cleavage in this case (Table 1) . Thus, initially cleavage occurs at D24 which results in only the loss of the N-terminal sequence. At slightly later times the remaining Ad E1A is cleaved at D150, producing two large fragments encompassing the N and C termini (1-150 and 151-266, respectively) . The N-terminal polypeptide is then rapidly degraded, while the C-terminal fragment is probably cleaved at D243 (giving 151-243) and D205 (giving 205-266). These smaller fragments were rather longer lived than the larger ones. The three largest fragments (labeled 1, 2, and 3 in Table 1 ) seen after Ponceau S staining had similar molecular weights to polypeptides 1, 2, and 3 in Fig. 3A . The smaller fragments could not be readily distinguished after proteolysis of in vitro translated protein due to the lack of methionine residues. The determined positions of the cleavage sites are indicated on the amino acid sequence of the protein shown in Fig. 7 .
Complex formation by Ad12 E1A caspase cleavage products
As the biological significance of the caspase-mediated cleavage of Ad E1A is not readily apparent, we decided to examine how the biological activity, as exemplified by protein binding, was affected. Thus, Ad12 E1A was treated with purified caspace 3 for various times. Aliquots were withdrawn from the reaction mix and fractionated by SDS-PAGE. The cleavage products were blotted onto nitrocellulose membranes which were then incubated with a number of Ad E1A binding proteins. These were chosen to represent proteins which bound to the N terminus (CBP) central region (TBP) and C terminus (CtBP) of Ad E1A. Protein bound to Ad E1A (or cleavage products) was detected with antibodies against GST (CBP-GST and CtBP-GST) or wt protein (TBP). It can be seen from the blots shown in Fig. 8 that CBP, TBP, and CtBP all interact with intact Ad E1A (Figs. 8B-8D ). CBP did not bind to any of the cleavage products of Ad12 E1A. Similarly, TBP was detected almost entirely in complex with full-length E1A (Fig. 8C) , although it can be seen, on the overexposed autoradiograph shown, that there was very limited interaction with a minor E1A degradation product. In contrast, CtBP bound strongly to the small caspase cleavage products which encompass amino acids H151 or G205 to the C terminus (Figs. 8D and 7) . 
TNF␣-/Ad E1A induced apoptosis
It is clear from the data presented above that a number of caspase cleavage sites are present within Ad12 E1A and that one of these is conserved in E1As from other viral serotypes (present in CR3). Significantly, we have shown that cleavage of Ad E1A occurs at these sites during cisplatin-induced apoptosis. We have gone on to examine the fate of Ad E1A under two different conditions: first, during Ad E1A-induced apoptosis and, second, during wt and mutant viral infection.
It is now well-established that the combination of TNF␣ and Ad E1A is able to induce apoptosis while each reagent alone has little effect (Chen et al., 1987; Duerksen-Hughes et al., 1989) . A549 cells were infected with Ad2 pm1722 (50 pfu/cell) and treated with TNF␣ (20 ng/ml) and Z-VAD-FMK (20 M) as indicated (Fig. 9 ). Cells were harvested at 24 and 48 h and analyzed by Western blotting and FACS. FACS analysis presented in and 9D ). The addition of Z-VAD-FMK inhibited the degradation of these proteins during apoptosis but had only a limited effect on cleavage which occurred during infection. Activation of caspase 3 was evident in the apoptotic samples but did not occur in response to virus or TNF␣ alone (Fig. 9E) .
Ad E1A stability during viral infection
Although it has been clearly demonstrated that caspase-mediated cleavage of Ad E1A occurs during both cisplatin-and Ad-E1A-induced apoptosis, the impli-FIG. 5. Cleavage of Ad E1A in human cell lysates by added caspases 3 and 8. Ad5 E1 HER911 cells were harvested and lysed by sonication in "caspase buffer" (see text). Activated caspases 3 and 8 were added and the mixture was incubated at 37°C for the times indicated. Aliquots were withdrawn and subjected to Western blotting using antibodies against Ad E1A, caspase 3, PARP, and lamin B as indicated. C, control untreated lysate of Ad5 E1 HER911 cells. Ϫ viruses can produce an apoptotic response. Interestingly, the addition of Z-VAD-FMK during wt virus infection caused increased production of progeny virus but also reduced release of viral particles (Chiou and White, 1998) . Against this background we considered that it would be appropriate to examine the fate of Ad E1A following infection with wt and Ad E1B 19K Ϫ viruses. Initially, an Ad E1B 19K
Ϫ virus (Ad2 pm1722) was studied. It has previously been shown that pm1722 produced extreme cytopathic effects similar to apoptosis after infection of HeLa cells (Barker and Berk, 1987 ) and this has also been shown to occur after infection of human fibroblasts and, to a lesser extent, A549 cells (our data not shown). However, the Western blots presented in Figs. 10A and 10B indicate that the overall level of Ad E1A expression is unaffected by the presence of the caspase inhibitor Z-VAD-FMK. When samples from infected cells were fractionated on gels in the presence of urea it was seen that the 12S E1A protein was considerably more stable than the 13S product (Figs. 10C-10F ). Similar patterns of protein expression were observed in the presence and absence of Z-VAD-FMK. Infection with wt Ad5 and Ad12 gave a similar pattern of E1A expression to that seen with Ad2 pm1722 (Figs. 10D and 10E ). 1988), showed similar levels of Ad12 E1A expression in the presence and absence of Z-VAD-FMK (data not shown).
We have concluded that a "normal" apoptotic response based on the activation of caspase 3 triggered during infection is not responsible for Ad E1A degradation. However, we have extended this study and examined to what extent protein degradation, usually associated with apoptosis, occurs during infection with Ad5 wt and Ad2 pm1722.
Caspase activation and cleavage of cellular proteins during adenovirus infection
Although little difference in Ad E1A expression during viral infection was observed with caspase inhibitors, we considered the possibility that some limited activation of caspases might occur, particularly in view of previous observations (Chiou and White, 1998) . Western blotting studies suggested slight caspase 3 activation during infection of A549 cells with Ad2 pm1722 and Ad12 pm700 and this was not appreciably affected by Z-VAD-FMK (Figs. 11A and 11B and data not shown, respectively). Interestingly, an increase in level of procaspase 3 expression was observed during the later stages of viral infection (Figs. 11A and 11B ). Virtually no activation of caspase 3 was seen during wt Ad5 or Ad12 wt infection (data not shown). Activation of caspase 3 was rather more marked following infection of fibroblasts with Ad2 pm1722 than A549 cells [Figs. 11A and 13B(ii) ].
Analysis of caspase 10 expression was also undertaken. Appreciable activation (evident as a reduction in the level of the 58K procaspase signal in the Western blots) was apparent during cisplatin-induced apoptosis of Ad E1A expressing transformed cells (data not shown). However, during viral infection with Ad2 pm1722 and Ad5 and Ad12 wt activation of caspase 10 was more limited although obvious (Figs. 11C-11F ). The addition of the inhibitor Z-VAD-FMK reduced the activation of caspase 10 slightly (compare Figs. 11C and 11D) . No activation of caspases 6, 7, and 8 was observed during infection with any of the viruses (data not shown). However, it was observed that purified caspase 10 degraded [
35 S]methionine-labelled in vitro translated Ad E1A to only a very limited extent.
The fate of two well-characterized caspase substrates was also examined during viral infection of A549 cells and human fibroblasts. Lamin B was rapidly degraded during wt Ad5 and Ad2 pm1722 infection of A549 cells; this was inhibited to a certain extent in the presence of Z-VAD-FMK, particularly following infection with pm1722 (Figs. 12A-12D ). The stability of PARP was also examined. During infection of A549 cells with wt Ad5 and Ad2 pm1722 some degradation of PARP took place and this was inhibited with Z-VAD-FMK (Figs. 12E-12H) .
Rather different results were obtained following the infection of human skin fibroblasts (Fig. 13) . Ad E1A was appreciably more stable, with the level of expression still increasing after several days (compare Fig. 13A with 10 and 9B, although it should be noted that in the A549 cells, unlike the fibroblasts, infection went virtually to completion). Caspase 3 activation was much more marked during infection of fibroblasts with Ad2 pm1722 [ Fig. 13B (ii)] and this was inhibited by Z-VAD-FMK [ Fig. 13B(iv) ]. As with A549 cells lamin B was cleaved during Ad2 pm1722 infection (Fig. 13C) and Ad5 wt infection (data not shown). Limited inhibition of this cleavage was observed in the presence of Z-VAD-FMK (Fig. 13C) . Degradation of lamin B following Ad5 wt infection of fibroblasts was similar to that shown in Fig. 13C for Ad2 pm1722. No degradation of PARP was observed with Ad2 pm1722 or Ad5 wt, although some increase in expression occurred at late times (data not shown). Thus, it is apparent that during infection with wt virus as well as with E1B 19K Ϫ virus a number of proteolytic events associated with apoptosis take place, even though caspase 3, 6, 7, and 8 activation is strictly limited. The effects vary with different target cell types.
DISCUSSION
The relationship between adenoviruses and apoptosis is complex (Roulston et al., 1999; White, 2001) . Expression of Ad E1A causes p53-mediated and p53-independent apoptosis following transfection into mammalian cells (Lowe and Ruley, 1993; Debbas and White, 1993; Subramanian et al., 1995; Teodoro et al., 1995) . Infection of human cells with mutant viruses lacking the gene encoding the E1B 19K protein also appears to cause apoptosis evident as a deg ϩ (DNA degradation), lp ϩ (large plaque), or cyt ϩ (cytolysis) phenotype (reviewed in Stillman, 1986) . Other adenovirus proteins are also involved in apoptosis-for example, E4 orf4 has been shown to induce cell death by a p53-independent mechanism (Lavoie et al., 1998) . In addition, products of the E3 gene protect virally infected cells from apoptosis induced by the host's immune system (reviewed in Wold and Tollefson, 1998) . Simplistically, it might be expected that adenoviruses would try to inhibit apoptosis during the early stages of infection to minimize the host's immune response so that viral replication has sufficient time to go to completion. Later cell lysis, to allow the release of the viral progeny, might be expected to utilize part of the cellular apoptotic mechanism. Up to now, however, most evidence supports the contention that during wild-type infection adenoviruses inhibit most aspects of apoptosis. Lysis of infected cells appears to be mediated by adenovirus death protein, an 11.6K molecular weight glycosylated polypeptide, encoded by the E3 region, which is expressed at high levels very late in infection (Tollefson et al., 1996a,b) and not by apoptosis.
During apoptosis many cellular proteins are degraded by caspases. We considered that it would be of interest to investigate whether caspase-mediated proteolysis could play a part in the observed reduction in level of E1A as adenovirus infection progresses. Initially, it was shown that in stable transformed human and rat cell lines expressing Ad2, Ad5, or Ad12 E1A induction of apoptosis with the DNA damaging agent cisplatin resulted in E1A degradation (Fig. 1) . Apoptosis and E1A proteolysis were inhibited by Z-VAD-FMK (Fig. 2) and other caspase inhibitors (data not shown). When the stability of the two major Ad E1A components was compared ( Fig. 6 ) it was noted that in Ad12 expressing cells both the 12S and the 13S proteins were degraded at the same rate. However, in the case of Ad2 and Ad5 E1A expressing cells the addition of cisplatin caused more rapid proteolysis of the larger 13S protein (Fig. 6) .
Results of in vitro studies using purified Ad E1A proteins and caspases were consistent with these observations. Thus, both Ad2 and Ad12 13S proteins were rapidly cleaved by caspase 3 (Fig. 3) . The Ad12 12S (and Ad12 13S) protein was cleaved by caspase 7 while the Ad2 E1A 12S protein was rather more stable, with only limited cleavage taking place (Figs. 3 and 4 ). Caspase 7 also had limited effect on purified Ad2 E1A 13S protein (Fig.  4) . When purified caspase 3 was added to lysates of Ad transformed cells E1A was cleaved together with PARP and lamin B (Fig. 5) . This is consistent with data obtained from the in vitro experiments (Figs. 3 and 4) . The presence of Ad E1B 19K protein (in the Ad E1 transformants) did not protect the proteins from caspase activity as it exerts its anti-apoptotic effects upstream of caspase activation. Purified caspase 8 also caused some proteolysis of Ad E1A in this assay (Fig. 5) due to its ability to directly cleave and activate caspase 3 (Fig. 5B) .
Cleavage of Ad E1A in vitro with caspases 3, 6, and 7 generally results in an initial small reduction in molecular weight (Figs. 3 and 4) . Studies with the Ad12 13S protein indicate that this is due to cleavage C terminal to D24 (Fig. 7) . This residue is not conserved in Ad2/5 but it is likely that cleavage occurs at D21 (D30 is an unlikely cleavage site due to the C-terminal sequence NLPPP). Cleavage does not occur at D24 in Ad12 12S E1A with either caspase 3 or 7 (Figs. 3 and 4) . The second major site of cleavage in Ad12 E1A 13S occurs at D150 in CR3 (Fig. 7 and Table 1 ). This residue is conserved in the Ad2/5 13S protein, although the C-terminal sequence differs-HPEL in Ad12 and YVEH in Ad2/5. Whether cleavage occurs at D150 in Ad12 12S E1A has not been definitively demonstrated but seems likely. The stability of Ad2/5 E1A 12S protein can be explained by the absence of CR3-removing the probable cleavage site at D145, equivalent to Ad12 D150. The comparable residue is present in both 12S and 13S Ad12 proteins. At later stages of treatment of Ad12 13S E1A with caspase 3 proteolysis occurs at aspartic acid residues in the Cterminal domain (encoded by exon 2) ( Fig. 7 and Table 1 ). Similar sequences are present in the Ad2/5 proteins. Probable cleavage sites in Ad2/5 13S E1A occur at D230, D233, and D271, although this has not been demonstrated experimentally. It appears, therefore, that both Ad2/5 13S E1A and both Ad12 E1A proteins are progressively degraded from the N terminus. This results in the loss of the N-terminal domain essential for binding p300/ CBP, p400, and proteasome components, followed by destruction of the TBP binding site in CR3 and separation of the C-terminal domain from the N-terminal region containing CR1 and CR2. Finally, these large polypeptides are further degraded.
The effect of caspase cleavage on the ability of Ad E1A to interact with a number of its known binding partners was investigated (Fig. 8) . Three representative binding proteins were examined-CBP, which interacts with the N-terminal region of E1A (Wang et al., 1993) , TBP, which has been considered to bind predominantly to CR3 (Horikoshi et al., 1991; Lee et al., 1991) , and CtBP, which interacts very close to the C terminus (Boyd et al., 1993) . CBP was shown not to interact with any of the cleavage products of Ad12 E1A, consistent with the observation that loss of the N-terminal region is an early event during caspase-mediated cleavage of Ad12 E1A. Only a very limited interaction of TBP was observed. If the major site of interaction were in CR3 it might be expected to bind to Ad12E1A25-266-which contains intact CR3. However, other more recent evidence suggests that TBP may interact preferentially with the N terminus (Song et al., 1995; Boyd et al., 2002) . Data presented here are consistent with this suggestion. The ability of C-terminal fragments of E1A to interact with CtBP is shown in Fig. 8D . Previously, binding of a C-terminal chymotryptic peptide of Ad12E1A (residues 187-266) has been demonstrated (Molloy et al., 2000) . These are, of course, in vitro studies and within the apoptotic cell caspase-mediated degradation of Ad E1A binding proteins will also be occurring; for example, degradation of pRb has been established for some years (Jaenicke et al., 1996) . It is beyond the scope of this investigation to determine the stability and binding capabilities of all of the known Ad E1A binding proteins but we have noted that CtBP1 and CtBP2 are relatively unaffected during apoptosis of Ad-E1A-expressing cells while CBP, p300, p130, p107, and TBP are degraded at similar times to Ad E1A after treatment with cisplatin. The caspase-mediated proteolysis of Ad E1A and the Ad E1A binding proteins occurs slightly after the observed breakdown of PARP and lamin B in the system investigated. Whether the observation that a caspasegenerated peptide from Ad E1A is able to bind to, and presumably neutralize the activity of, CtBP, a protein which is not degraded in apoptotic cells, is of particular significance will have to await further investigation. However, it is interesting to note that peptide fragments of Ad E1A do not appear to bind to the partner proteins which are themselves substrates for caspases in apoptotic cells.
These studies were extended to consider the fate of Ad E1A when it is responsible for producing an apoptotic response. It is now well-established that following infection with an Ad E1B
Ϫ mutant virus and treatment with TNF␣ cells become apoptotic. We have demonstrated that during this process Ad E1A is degraded by caspases (Fig. 9 ). In the absence of TNF␣ no characteristic Ad E1A degradation product was visible. However, in the presence of TNF␣ but in the absence of Z-VAD-FMK a truncated Ad2 E1A protein could be distinguished (Fig. 9B ). This was of comparable size to the Ad2 E1A degradation product seen during cisplatin treatment of Ad2 expressing cells (Fig. 1D) .
Significantly, the level of expression of Ad E1A was similar during wt and mutant virus infection in the presence and absence of the caspase inhibitor Z-VAD-FMK. During viral infection the 13S Ad E1A component was shown to be much less stable than the smaller protein (Fig. 10 ). This loss of Ad 13S E1A is probably not due to the action of caspases since the addition of caspase inhibitors had very little effect on Ad E1A expression levels ( Fig. 10 and data not shown). Consistent with this, only marginal activation of caspase 3 was observed during wt viral infection, although limited conversion of inactive procaspase 3 to the active enzyme was apparent during infection with Ad2 pm1722 (compare Figs. 1  and 11 ). It is probably to be expected that caspase 3 would not be activated during wt viral infection as this would lead to activation of ICAD, activation of the nuclease CAD, and cleavage of viral and cellular DNA (Liu et al., 1997) . It is interesting to note, however, that caspase 3 activation was more marked following Ad2 pm1722 infection of human fibroblasts than of A549 cells (compare Figs. 11A and 13B) . No activation of caspases 6, 7, and 8 (data not shown) was observed although limited Z-VAD-FMK inhibitable loss of procaspase 10 was seen (Figs. 11C-11F ). Thus, although it is generally considered that the 19K Ϫ viruses induce an apoptotic state, many of the diagnostic features associated with it (in particular caspase activation) are not as prominent as those seen following the addition of reagents which produce a classical apoptotic response (e.g., DNA damaging reagents).
These studies were extended to see to what extent the generalized caspase-mediated proteolysis normally associated with apoptosis occurred during viral infection. Degradation of lamin B and PARP has previously been found to be an accurate diagnostic marker of apoptosis. In the studies presented here cleavage of lamin B was observed during viral infection of A549 cells and human fibroblasts (Figs. 12 and 13C ). This occurred both in the absence and in the presence of Z-VAD-FMK and occurred with Ad E1B 19K
Ϫ as well as wt virus. However, some limited inhibition of lamin B proteolysis was observed following viral infection of A549 cells and fibroblasts when the caspase inhibitor was present. It has previously been observed that proteolysis of PARP in response to infection with Ad5 E1B 19K Ϫ virus (dl 337) occurred irrespective of the presence of Z-VAD-FMK (Chiou and White, 1998) . In our studies using A549 cells PARP was degraded following infection with wt or mutant viruses. In both cases proteolysis was reduced to some extent by Z-VAD-FMK (Figs. 12E-12H ). Only slight proteolysis of PARP was seen following the infection of human skin fibroblasts. Again, these data are further evidence of the differences between cell death due to viral infection, even by Ad E1B 19K
Ϫ mutants, and apoptosis. In the former case protein degradation appears to be somewhat limited and to be largely, although not entirely, caspase independent. It is possible, therefore, that an alternative proteolytic system could be activated during viral infection and that this could produce some, but not all, of the morphological effects usually associated with apoptosis.
In summary, we have demonstrated here significant caspase-mediated cleavage of Ad E1A during apoptosis but not during viral infection when degradation of Ad E1A can be attributed to non-caspase-mediated proteolysis. Lamin B and PARP cleavage during infection is probably primarily due to the action of virally activated proteases which are not inhibited by caspase inhibitors. The degradation of these proteins is host cell type dependent.
MATERIALS AND METHODS
Cell lines and virus infection
Ad12 E1A HLBRK and Ad12 E1A ϩ E1B 19K HLBRK cell lines were produced by transfection of DNA encoding Ad12 E1A (AccIH fragment) or Ad12 E1A and Ad12 E1B 19K (HindIII G fragment) into hooded Lister baby rat kidney (HLBRK) cells (Gallimore et al., 1985b) . Ad12 E1A ϩ mutant ras HER and Ad2 E1A ϩ mutant ras HER cell lines were produced by transfection of Ad E1A DNA together with activated mutant N or H ras DNA into human embryo retinoblast (HER) cells (Byrd et al., 1988) . The following lines were used in this study: Ad12 E1A HLBRK 7, Ad12 E1A HLBRK5, Ad12 E1A ϩ E1B 19K HLBRK2, Ad12 E1A ϩ E1B 19K HLBRK3, Ad12 E1A ϩ E1B 19K HLBRK4, Ad12 E1A ϩ H ras HER 414B, Ad12 E1A ϩ N ras HER 387.2, Ad2 E1A ϩ N ras HER 313A, Ad2 E1A ϩ N ras HER 313C, Ad2 E1A ϩ H ras HER 414.2. A549 cells derive from a human small cell lung carcinoma and were used for some viral infection experiments. A549 cells were infected with wt Ad5 and Ad12 and with the E1B 19K Ϫ viruses Ad2 pm1722 (Barker and Berk, 1987) and Ad12 pm700 (Edbauer et al., 1988) . Ad2 pm1722 is in a dl309 background, lacking part of the E3 gene. Fibroblasts from an adult male donor were infected with wt Ad5 or with Ad2 pm1722. Most infections were at 50 pfu/cell, although occasionally an infectivity of 200 pfu/ cell was used. All cells were grown in DMEM buffered with HEPES containing glutamine (2 mM) and FCS (8%).
Apoptosis
Apoptosis was induced by the addition of cisplatin to the tissue culture medium at a concentration of 15-30 g/ml, depending on the cell line. The extent of apoptosis was estimated by counting the acridine-orangestained cells or by FACS analysis. FACS analysis was carried out essentially as described by Grand et al. (1998a) . Briefly, cells were harvested following trypsinization and fixed in 70% ethanol at Ϫ20°C. Cells were then treated with RNAse A (50 g/ml) and labeled with propidium iodide (5 g/ml) prior to analysis using a Coulter Epics XL flow cytometer. The percentage of cells in each phase of the cycle was determined using a multicycle version of 2.53 (Phoenix). DNA profiles were processed using Win MDI version 2.5.
To examine Ad E1A sensitization to TNF␣-induced cytolysis A549 cells were infected with Ad2 pm1722 (50 pfu/cell) and treated with TNF␣ (20 ng/ml). Experiments were carried out in the presence and absence of Z-VAD-FMK (20 M).
Western blotting
Cells were washed with cold saline, dislodged from the tissue culture plastic, and pelleted by centrifugation. Cells were solubilized in 9 M urea, 50 mM Tris HCl, pH 7.4, 0.15 M ␤-mercaptoethanol. Aliquots containing 30 g protein were subjected to SDS-PAGE in the presence of 0.1 M Tris, 0.1 M bicine, pH 8.3, and 0.1% SDS. Western blotting was carried out using conventional protocols. Proteins were also fractionated on 15% polyacrylamide gels run in the presence of 7 M urea, 15 mM Tris, 93 mM glycine, pH 8.3 (but in the absence of SDS), followed by Western blotting (Grand and Gallimore, 1984) . "Urea gels" have been used in the past to separate relatively lowmolecular-weight acidic proteins which have marked differences in charge or conformation rather than size, for example, different phosphorylated or Ca 2ϩ -bound forms (Head and Perry, 1974) . Proteins are retained in solution in the presence of the urea and will migrate into the gel so long as they are highly negatively charged (a preponderance of acidic amino acids) and comprise less than about 400 residues.
For the detection of interaction of E1A caspase 3 cleavage products with E1A binding proteins Ad12 E1A (20 g) was incubated with purified caspase 3 at 37°C as described below. After SDS-PAGE and electrophoretic transfer nitrocellulose membranes were incubated for 2 h with CBP-GST fragment (2 g/ml), CtBP1-GST (2 g/ml), or in vitro translated TBP (50 l reaction mix). After the washings, bound CBP or CtBP1 were detected using an antibody raised against GST (Amersham Pharmacia). Bound TBP was detected using an antibody against the intact protein (Upstate Biotechnology, Inc.).
Antibodies
Ad12 E1A was usually detected with a mouse monoclonal antibody (E1A mab13) and occasionally with rat tumor bearer serum or a sheep polyclonal antibody. Ad2/5 E1A was detected with the mouse monoclonal M58 (PharMingen). Neither of these reagents reacted with any cellular polypeptide-nor did they react with any lower molecular weight Ad E1A product in nonapoptotic cells. Antibodies against caspases 3 and 7 were from PharMingen. Antibodies against caspases 6, 8, and 10 were from Upstate Biotechnology, Inc. Lamin B was detected with a goat polyclonal antibody from Santa Cruz Biotech. PARP antibody (monoclonal clone C-2-10) was from Sigma. TNF␣ was from R&D Systems.
Protein preparation
Ad12 E1A 13S was expressed in Escherichia coli and purified under denaturing conditions as previously described (Grand et al., 1998b) . Protein was renatured by prolonged dialysis against 10 mM NH 4 HCO 3 , pH 7.9. Ad2, Ad12 E1A, and TBP, cloned into T7-driven expression plasmids, were in vitro translated using the TNT-coupled rabbit-reticulocyte system (Promega) in the presence of L-␣-[
35 S]methionine, according to the manufacturer's instructions.
CtBP1 and the Ad E1A binding fragment of CBP (amino acids 1460-1891) were expressed in E. coli as GST fusion proteins and purified using glutathione-agarose beads.
Amino acid sequencing was carried out on peptides blotted onto PVDF membranes using a Perkin-Elmer/ AB1 473A sequencer by Alta Bioscience, University of Birmingham. Five cycles were performed on each peptide.
Caspase assays
In vitro translated L-␣-[
35 S]methionine Ad E1A (50 l) was incubated at 37°C with purified caspases (3, 6, 7, and 8 [PharMingen] ) in 25 mM PIPES, pH 7.3, 10 mM DTT, 1 mM EDTA, 10% sucrose, 0.1% CHAPS, 0.1 M NaCl (caspase buffer). Aliquots were withdrawn at appropriate times and the reaction was stopped by the addition of SDS sample buffer. Purified Ad12 E1A 13S protein was incubated with purified caspases 3, 6, 7, and 8 at 37°C in caspase buffer. Aliquots were withdrawn at appropriate times and the reaction was stopped with SDS sample buffer.
Cells (Ad2E1A ϩ Nras HER313A, Ad5E1HER911, and A549) were washed twice with ice-cold saline and harvested by aspiration. Caspase buffer (0.5 ml) was added to the cell pellets, which were then sonicated. Insoluble material was removed by centrifugation (35K rpm for 30 min). Protein lysate (100 g) was incubated with purified caspase 3 or 8 at 37°C. Aliquots were withdrawn at appropriate times and added to SDS sample buffer. Protein cleavage was detected by Western blotting.
Apoptosis and in vitro caspase activity was inhibited by the addition of Z-VAD-FMK, Z-DEVD-FMK, and Z-YVAD-FMK. The inhibitors were present in the tissue culture medium at a concentration of 20 M.
